Jerel Vega

919 total citations
10 papers, 407 citations indexed

About

Jerel Vega is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Jerel Vega has authored 10 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Molecular Biology and 4 papers in Virology. Recurrent topics in Jerel Vega's work include HIV Research and Treatment (4 papers), RNA Interference and Gene Delivery (3 papers) and Virus-based gene therapy research (2 papers). Jerel Vega is often cited by papers focused on HIV Research and Treatment (4 papers), RNA Interference and Gene Delivery (3 papers) and Virus-based gene therapy research (2 papers). Jerel Vega collaborates with scholars based in United States, Belgium and France. Jerel Vega's co-authors include Priya Karmali, Kiyoshi Tachikawa, Pad Chivukula, Nina Tonnu, Inder M. Verma, Pattraranee Limphong, Suvasini Ramaswamy, Padmanabh Chivukula, Marciano Sablad and Steven A. Kwilas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Scientific Reports.

In The Last Decade

Jerel Vega

10 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerel Vega United States 7 292 105 100 70 40 10 407
Neha J. Pancholi United States 7 197 0.7× 38 0.4× 125 1.3× 67 1.0× 88 2.2× 7 341
Phillip Heaton United States 9 258 0.9× 76 0.7× 35 0.3× 59 0.8× 86 2.1× 13 390
Robert E. Throm United States 11 199 0.7× 53 0.5× 183 1.8× 87 1.2× 69 1.7× 21 485
Hayley E. Raymond United States 6 247 0.8× 90 0.9× 201 2.0× 64 0.9× 48 1.2× 13 451
Avelino Teixeira United States 12 238 0.8× 48 0.5× 93 0.9× 126 1.8× 40 1.0× 19 405
Christina Öhrmalm Sweden 9 307 1.1× 49 0.5× 87 0.9× 47 0.7× 64 1.6× 12 420
Shiho Morimoto Japan 6 370 1.3× 104 1.0× 32 0.3× 334 4.8× 83 2.1× 9 590
Saliha Majdoul United States 10 152 0.5× 79 0.8× 69 0.7× 129 1.8× 59 1.5× 14 328
Tom Cremer Netherlands 5 361 1.2× 121 1.2× 17 0.2× 76 1.1× 56 1.4× 5 447
Miles Smith United States 10 152 0.5× 86 0.8× 31 0.3× 125 1.8× 100 2.5× 16 377

Countries citing papers authored by Jerel Vega

Since Specialization
Citations

This map shows the geographic impact of Jerel Vega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerel Vega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerel Vega more than expected).

Fields of papers citing papers by Jerel Vega

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerel Vega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerel Vega. The network helps show where Jerel Vega may publish in the future.

Co-authorship network of co-authors of Jerel Vega

This figure shows the co-authorship network connecting the top 25 collaborators of Jerel Vega. A scholar is included among the top collaborators of Jerel Vega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerel Vega. Jerel Vega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Pardons, Marion, et al.. (2025). Blood and tissue HIV-1 reservoirs display plasticity and lack of compartmentalization in virally suppressed people. Nature Communications. 16(1). 2173–2173. 3 indexed citations
2.
Falcinelli, Shane D., Ellen Van Gulck, Brigitte Allard, et al.. (2024). Nanoparticle delivery of Tat synergizes with classical latency reversal agents to express HIV antigen targets. Antimicrobial Agents and Chemotherapy. 68(7). e0020124–e0020124. 4 indexed citations
3.
Pardons, Marion, Willem van Snippenberg, Sofie Rutsaert, et al.. (2023). Potent latency reversal by Tat RNA-containing nanoparticle enables multi-omic analysis of the HIV-1 reservoir. Nature Communications. 14(1). 8397–8397. 22 indexed citations
4.
Gulck, Ellen Van, Marion Pardons, Christel Van den Eynde, et al.. (2023). A truncated HIV Tat demonstrates potent and specific latency reversal activity. Antimicrobial Agents and Chemotherapy. 67(11). e0041723–e0041723. 9 indexed citations
5.
Dı́az-Trelles, Ramón, Sharon Lee, Jenny Park, et al.. (2022). Lipid nanoparticle delivers phenylalanine ammonia lyase mRNA to the liver leading to catabolism and clearance of phenylalanine in a phenylketonuria mouse model. Molecular Genetics and Metabolism Reports. 32. 100882–100882. 5 indexed citations
6.
Pérez‐García, Carlos G., Ramón Dı́az-Trelles, Jerel Vega, et al.. (2022). Development of an mRNA replacement therapy for phenylketonuria. Molecular Therapy — Nucleic Acids. 28. 87–98. 45 indexed citations
7.
Ngono, Annie Elong, José Ángel Regla-Nava, Darina Spasova, et al.. (2020). CD8 + T cells mediate protection against Zika virus induced by an NS3-based vaccine. Science Advances. 6(45). 29 indexed citations
8.
Perley, Casey C., Rebecca L. Brocato, Hua Wu, et al.. (2020). Anti-HFRS Human IgG Produced in Transchromosomic Bovines Has Potent Hantavirus Neutralizing Activity and Is Protective in Animal Models. Frontiers in Microbiology. 11. 832–832. 19 indexed citations
9.
Mucker, Eric M., Priya Karmali, Jerel Vega, et al.. (2020). Lipid Nanoparticle Formulation Increases Efficiency of DNA-Vectored Vaccines/Immunoprophylaxis in Animals Including Transchromosomic Bovines. Scientific Reports. 10(1). 8764–8764. 35 indexed citations
10.
Ramaswamy, Suvasini, Nina Tonnu, Kiyoshi Tachikawa, et al.. (2017). Systemic delivery of factor IX messenger RNA for protein replacement therapy. Proceedings of the National Academy of Sciences. 114(10). E1941–E1950. 236 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026